These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Demarosi F, Soligo D, Lodi G, Moneghini L, Sardella A, Carrassi A. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918 [Abstract] [Full Text] [Related]
3. Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation. Montebugnoli L, Gissi DB, Marchetti C, Foschini MP. Int J Oral Maxillofac Surg; 2011 May; 40(5):556-8. PubMed ID: 21163622 [Abstract] [Full Text] [Related]
4. A case of tongue carcinoma associated with chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Noguchi K, Nakase M, Inui M, Nakamura S, Okumura K, Tagawa T. Aust Dent J; 2010 Jun; 55(2):200-2. PubMed ID: 20604764 [Abstract] [Full Text] [Related]
5. Oral malignancies following HSCT: graft versus host disease and other risk factors. Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A. Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755 [Abstract] [Full Text] [Related]
6. Elastin metabolism is disrupted in patients after allogeneic hematopoietic stem cell transplantation (alloHSCT) for acute and chronic myeloid leukemia. Helbig G, Krzemień S, Francuz T, Wojnar J, Hołowiecki J. Med Sci Monit; 2008 Nov; 14(11):CR584-8. PubMed ID: 18971876 [Abstract] [Full Text] [Related]
7. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan. Chen MH, Chang PM, Li WY, Hsiao LT, Hong YC, Liu CY, Gau JP, Liu JH, Chen PM, Chiou TJ, Tzeng CH. Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906 [Abstract] [Full Text] [Related]
9. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, Janin A, Soulier J, Gluckman E, Socié G. Cancer; 2008 Dec 15; 113(12):3315-22. PubMed ID: 18831513 [Abstract] [Full Text] [Related]
10. Anterior uveitis: a manifestation of graft-versus-host disease. Hettinga YM, Verdonck LF, Fijnheer R, Rijkers GT, Rothova A. Ophthalmology; 2007 Apr 15; 114(4):794-7. PubMed ID: 17187864 [Abstract] [Full Text] [Related]
13. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Huang XJ, Jiang Q, Chen H, Xu L, Liu D, Chen Y, Han W, Zhang Y, Liu K, Lu D. Bone Marrow Transplant; 2005 Aug 15; 36(4):343-8. PubMed ID: 15968295 [Abstract] [Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
15. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Creamer D, Martyn-Simmons CL, Osborne G, Kenyon M, Salisbury JR, Devereux S, Pagliuca A, Ho AY, Mufti GJ, du Vivier AW. Arch Dermatol; 2007 Sep 15; 143(9):1157-62. PubMed ID: 17875877 [Abstract] [Full Text] [Related]
16. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, Taji H, Kitaori K, Goto S, Iida H, Morishima Y, Kodera Y, Naoe T, Morishita Y. Bone Marrow Transplant; 2005 Jul 15; 36(2):115-21. PubMed ID: 15908969 [Abstract] [Full Text] [Related]